Tesla, Inc.
TSLA · Nasdaq · CIK 0001318605
SIC 3711
Motor Vehicles & Passenger Car Bodies
Category
Transportation Equipment
Entity
operating
Incorp.
TX
Fiscal Y/E
1231
Source: SEC EDGAR · All filings on SEC →
Investment Indicators
$445.03
+16.68 (+3.89%)
Open
$422.16
High
$449.16
Low
$416.80
Prev Close
$428.35
Volume
72,553,548
52W High
$498.83
52W Low
$273.21
50-day MA
$382.79
Quote as of: 2026-05-11
Market Cap
$1.55T
P/E
384.85
P/B
17.53
PEG
5.40
EPS
1.07
BPS
21.90
Beta
1.79
ROE
4.62%
ROA
2.75%
D/E Ratio
0.67
Current Ratio
2.16
Gross Margin
18.03%
Operating Margin
4.59%
Net Margin
4.00%
Book Value/Share
$21.90
Intrinsic Value Estimates
Multiple valuation methods, each with its own assumptions — outputs can diverge widely
Median consensus (6 methods)
$70.32B
| Method | Implied market cap | vs current |
|---|---|---|
Graham Number √(22.5 × 순이익 × 자본) | $83.74B | +1747% |
Graham Formula 순이익 × (8.5 + 2 × 성장률%) | — | N/A |
Justified P/E 순이익 × 산업 평균 P/E | $56.91B | +2618% |
P/B 배수 자본 × 산업 평균 P/B | $123.21B | +1155% |
P/S 배수 매출 × 산업 평균 P/S | $189.65B | +715% |
DCF (Gordon) CF × (1+g) / (r − g) | $55.41B | +2691% |
DDM (Gordon) D × (1+g) / (r − g) | $10.14B | +15152% |
▶ Detailed analysis — formula walk-through & scenarios
Why this conclusion
Of the 7 valuation methods, 6 were applicable. Their median fair-value lands +2099.2% below the current market cap → the stock trades above most formulas' estimates (overvalued). 6 methods flag overvalued, 0 flag undervalued, the rest land within fair range. Read each formula's assumptions below before treating any single number as the answer.
Graham Number
Overvalued +1747.0%√(22.5 × 순이익 × 자본)
Current
$1.55T
Implied fair
$83.74B
Gap (current − fair)
+$1.46T(+1747.0%)
NetIncome = $3.79B Equity = $82.14B √(22.5 × $3.79B × $82.14B) = $83.74B
- 최대 PER 15배
- 최대 PBR 1.5배
- 안정적 흑자 기업 가정 (금융·고성장 부정확)
Graham Formula
순이익 × (8.5 + 2 × 성장률%)
Not applicable: -
Justified P/E
Overvalued +2617.6%순이익 × 산업 평균 P/E
Current
$1.55T
Implied fair
$56.91B
Gap (current − fair)
+$1.49T(+2617.6%)
NetIncome = $3.79B Industry P/E = 15× $3.79B × 15 = $56.91B
- 산업 평균 PER 15x 가정 (사용자 정의 가능)
- 동종 업종 비교가 핵심 — 산업별 평균 P/E 사용 권장
P/B 배수
Overvalued +1155.3%자본 × 산업 평균 P/B
Current
$1.55T
Implied fair
$123.21B
Gap (current − fair)
+$1.42T(+1155.3%)
Equity = $82.14B Industry P/B = 1.5× $82.14B × 1.5 = $123.21B
- 산업 평균 PBR 1.5x 가정
- 은행·보험·자산집약적 산업에 특히 유효
P/S 배수
Overvalued +715.5%매출 × 산업 평균 P/S
Current
$1.55T
Implied fair
$189.65B
Gap (current − fair)
+$1.36T(+715.5%)
Revenue = $94.83B Industry P/S = 2× $94.83B × 2 = $189.65B
- 산업 평균 PSR 2x 가정
- 매출 기반 — 적자 기업·신생 기업에 적용 가능
- 이익률 차이 무시
DCF (Gordon)
Overvalued +2690.9%CF × (1+g) / (r − g)
Current
$1.55T
Implied fair
$55.41B
Gap (current − fair)
+$1.49T(+2690.9%)
FCF = $6.22B Discount r = 4.0% + 5.0% = 9.0% Growth g = -2.0% $6.22B × (1 + -2.0%) / (9.0% − -2.0%) = $55.41B
- 현금흐름 입력: FCF (잉여현금흐름)
- 할인율 9.0% (무위험 4.0% + 주식위험프리미엄 5.0%)
- 영구 성장률 -2.0% (실질 GDP 수준)
DDM (Gordon)
Overvalued +15151.7%D × (1+g) / (r − g)
Current
$1.55T
Implied fair
$10.14B
Gap (current − fair)
+$1.54T(+15151.7%)
- 배당 입력: 순이익의 30% (이론적 배당 — 무배당주 평가용 가정)
- 할인율 9.0%
- 배당 영구 성장률 -2.0%
DCF sensitivity: discount rate × terminal growth
Each cell is the (current vs FCF × (1+g) / (r − g)) discount % under the assumed growth g and discount r.
| g \ r | 7% | 8% | 9% | 10% | 11% |
|---|---|---|---|---|---|
| 1% | +1377.1% | +1623.3% | +1869.5% | +2115.6% | +2361.8% |
| 2% | +1118.8% | +1362.6% | +1606.4% | +1850.2% | +2093.9% |
| 3% | +865.6% | +1107.0% | +1348.4% | +1589.8% | +1831.2% |
| 4% | +617.2% | +856.3% | +1095.4% | +1334.5% | +1573.6% |
| 5% | +373.6% | +610.4% | +847.2% | +1084.0% | +1320.8% |
All estimates rest on strong assumptions. Treat the spread, not any single number, as the signal.
Financial Statements
In USD millions (per-share figures shown directly) · Financials as of: 2026-01-29
Income Statement
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 94,827 | 97,690 | 96,773 | 81,462 | 53,823 |
| Cost of Revenue | 77,733 | 80,240 | 79,113 | 60,609 | 40,217 |
| Gross Profit | 17,094 | 17,450 | 17,660 | 20,853 | 13,606 |
| Operating Expenses | 12,739 | 10,374 | 8,769 | 7,197 | 7,083 |
| Operating Income | 4,355 | 7,076 | 8,891 | 13,656 | 6,523 |
| Net Income | 3,794 | 7,091 | 14,997 | 12,556 | 5,519 |
| EPS (Basic) | 1.18 | 2.23 | 4.73 | 4.02 | 5.60 |
| EPS (Diluted) | 1.08 | 2.04 | 4.30 | 3.62 | 4.90 |
Balance Sheet
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | 137,806 | 122,070 | 106,618 | 82,338 | 62,131 |
| Current Assets | 68,642 | 58,360 | 49,616 | 40,917 | 27,100 |
| Cash & Equivalents | 16,513 | 16,139 | 16,398 | 16,253 | 17,576 |
| Total Liabilities | 54,941 | 48,390 | 43,009 | 36,440 | 30,548 |
| Current Liabilities | 31,714 | 28,821 | 28,748 | 26,709 | 19,705 |
| Long-term Debt | 6,584 | 5,535 | 2,682 | 1,029 | 4,254 |
| Total Equity | 82,137 | 72,913 | 62,634 | 44,704 | 30,189 |
Cash Flow
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating CF | 14,747 | 14,923 | 13,256 | 14,724 | 11,497 |
| Investing CF | -15,478 | -18,787 | -15,584 | -11,973 | -7,868 |
| Financing CF | 1,139 | 3,853 | 2,589 | -3,527 | -5,203 |
| CapEx | 8,527 | 11,339 | 8,898 | 7,158 | 6,482 |
📄 SEC Filings
Quarterly Report
10-Q
2026-04-23
Open →
Current Report
8-K
2026-04-22
Open →
Current Report
8-K
2026-04-02
Open →
Annual Report
10-K
2026-01-29
Open →
Current Report
8-K
2026-01-28
Open →
Current Report
8-K
2026-01-02
Open →
Current Report
FORM 8-K
2025-11-07
Open →
Quarterly Report
10-Q
2025-10-23
Open →
Current Report
8-K
2025-10-22
Open →
Current Report
8-K
2025-10-02
Open →
Proxy Statement
FORM DEF 14A
2025-09-17
Open →
Current Report
FORM 8-K
2025-09-05
Open →
Other filings (88)
Insider Transaction
OWNERSHIP DOCUMENT
2026-05-04
Open →
10-K/A
FORM 10-K/A
2026-04-30
Open →
144
xsl144X01/primary_doc.xml
2026-04-30
Open →
SCHEDULE 13G
xslSCHEDULE_13G_X02/primary_doc.xml
2026-04-30
Open →
S-8
FORM S-8
2026-04-27
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X02/primary_doc.xml
2026-04-23
Open →
Insider Transaction
OWNERSHIP DOCUMENT
2026-04-23
Open →
Insider Transaction
PRIMARY DOCUMENT
2026-04-02
Open →
Insider Transaction
OWNERSHIP DOCUMENT
2026-04-01
Open →
144
xsl144X01/primary_doc.xml
2026-03-30
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X02/primary_doc.xml
2026-03-27
Open →
Insider Transaction
OWNERSHIP DOCUMENT
2026-03-09
Open →
144
xsl144X01/primary_doc.xml
2026-03-06
Open →
Insider Transaction
OWNERSHIP DOCUMENT
2026-02-27
Open →
144
xsl144X01/primary_doc.xml
2026-02-25
Open →
Insider Transaction
PRIMARY DOCUMENT
2026-01-12
Open →
Insider Transaction
OWNERSHIP DOCUMENT
2026-01-06
Open →
144
xsl144X01/primary_doc.xml
2026-01-02
Open →
Insider Transaction
OWNERSHIP DOCUMENT
2025-12-31
Open →
Insider Transaction
OWNERSHIP DOCUMENT
2025-12-11
Open →
Insider Transaction
OWNERSHIP DOCUMENT
2025-12-09
Open →
144
xsl144X01/primary_doc.xml
2025-12-09
Open →
144
xsl144X01/primary_doc.xml
2025-12-08
Open →
Insider Transaction
OWNERSHIP DOCUMENT
2025-11-12
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X01/primary_doc.xml
2025-11-10
Open →
Insider Transaction
OWNERSHIP DOCUMENT
2025-11-10
Open →
S-8
FORM S-8
2025-11-10
Open →
DEFA14A
DEFA14A
2025-11-06
Open →
DEFA14A
DEFA14A
2025-11-05
Open →
PX14A6G
BOWYER RESEARCH - PX14A6G
2025-11-05
Open →
PX14A6G
BOWYER RESEARCH - PX14A6G
2025-11-05
Open →
DEFA14A
DEFA14A
2025-11-04
Open →
DEFA14A
DEFA14A
2025-11-03
Open →
DEFA14A
DEFA14A
2025-10-31
Open →
DEFA14A
DEFA14A
2025-10-30
Open →
DEFA14A
DEFA14A
2025-10-29
Open →
DEFA14A
DEFA14A
2025-10-28
Open →
PX14A6G
i1028250px14a6g.htm
2025-10-28
Open →
DEFA14A
DEFA14A
2025-10-27
Open →
PX14A6G
o1027253px14a6g.htm
2025-10-27
Open →
PX14A6G
EXEMPT SOLICIATION
2025-10-27
Open →
DEFA14A
DEFA14A
2025-10-23
Open →
DEFA14A
DEFA14A
2025-10-22
Open →
DEFA14A
DEFA14A
2025-10-21
Open →
DEFA14A
DEFA14A
2025-10-20
Open →
DEFA14A
DEFA14A
2025-10-17
Open →
PX14A6G
g1016251px14a6g.htm
2025-10-16
Open →
DEFA14A
DEFA14A
2025-10-15
Open →
DEFA14A
DEFA14A
2025-10-14
Open →
DEFA14A
DEFA14A
2025-10-10
Open →
DEFA14A
DEFA14A
2025-10-09
Open →
PX14A6G
i108250px14a6g.htm
2025-10-08
Open →
DEFA14A
DEFA14A
2025-10-07
Open →
DEFA14A
DEFA14A
2025-10-06
Open →
DEFA14A
DEFA14A
2025-10-06
Open →
DEFA14A
DEFA14A
2025-10-03
Open →
DEFA14A
DEFA14A
2025-10-02
Open →
PX14A6G
o102255px14a6g.htm
2025-10-02
Open →
PX14A6G
j102251px14a6g.htm
2025-10-02
Open →
DEFA14A
DEFA14A
2025-10-01
Open →
DEFA14A
DEFA14A
2025-09-30
Open →
DEFA14A
DEFA14A
2025-09-29
Open →
DEFA14A
DEFA14A
2025-09-26
Open →
DEFA14A
DEFA14A
2025-09-25
Open →
DEFA14A
DEFA14A
2025-09-24
Open →
PX14A6G
p924253px14a6g.htm
2025-09-24
Open →
DEFA14A
DEFA14A
2025-09-23
Open →
DEFA14A
DEFA14A
2025-09-22
Open →
PX14A6G
NATIONAL CENTER FOR PUBLIC POLICY RESEARCH - PX14A6G
2025-09-22
Open →
DEFA14A
DEFA14A
2025-09-19
Open →
DEFA14A
DEFA14A
2025-09-18
Open →
Insider Transaction
OWNERSHIP DOCUMENT
2025-09-17
Open →
DEFA14A
DEFA14A
2025-09-17
Open →
DEFA14A
DEFA14A
2025-09-17
Open →
DEFA14A
DEFA14A
2025-09-17
Open →
ARS
ARS
2025-09-17
Open →
DEFA14A
DEFA14A
2025-09-17
Open →
DEFA14A
DEFA14A
2025-09-16
Open →
144
xsl144X01/primary_doc.xml
2025-09-15
Open →
DEFA14A
DEFA14A
2025-09-15
Open →
Insider Transaction
OWNERSHIP DOCUMENT
2025-09-15
Open →
Insider Transaction
PRIMARY DOCUMENT
2025-09-12
Open →
DEFA14A
DEFA14A
2025-09-12
Open →
144
xsl144X01/primary_doc.xml
2025-09-11
Open →
Insider Transaction
OWNERSHIP DOCUMENT
2025-09-09
Open →
DEFA14A
DEFA14A
2025-09-08
Open →
144
xsl144X01/primary_doc.xml
2025-09-08
Open →
DEFA14A
DEFA14A
2025-09-05
Open →